M Ventures
M Ventures invests in innovative technologies and products with the potential to significantly impact Merck‘s core business areas.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed M Ventures Information
Geographic Data
Address: Gustav Mahlerplein 102 Toyo lto Building
City: Amsterdam
State: noord-holland
Zip: 1082 MA
Country: NL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$677M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
8,401,931Website Global Rank
315Website Monthly Traffic
Twitter Followers
Description
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2018 | ApoGen Biotechnologies | Series A | 4M |
| 1/2017 | ARTSaVIT | Series A | 6.3M |
| 11/2021 | Biolinq | Series B | 0 |
| 9/2020 | NanoSyrinx | Pre Seed Round | - |
| 7/2020 | iOnctura | Series A | 5.8M |
| 7/2021 | Wiliot | Series C | 0 |
| 11/2020 | F-Star Therapeutics | Post-IPO Equity | 0 |
| 1/2017 | Macrophage Pharma | Series A | 0 |
| 5/2018 | Gamelynx | Equity | 1.2M |
| 8/2021 | Immunitas Therapeutics | Series B | 0 |
| 2/2017 | Prexton Therapeutics | Series B | 31.1M |
| 3/2022 | Concerto Biosciences | Equity | 24.5M |
| 11/2021 | NeoLogic (VLSI) | Seed Round | 2.8M |
| 7/2021 | Artios Pharma | Series C | 0 |
| 10/2018 | Galecto | Series C | 90.2M |
| 8/2018 | Vantage Point | Pre Seed Round | 1.4M |
| 6/2017 | Indi Molecular | Series A | 0 |
| 7/2021 | NanoSyrinx | Seed Round | 8.5M |
| 5/2020 | SynSense | Series A | - |
| 9/2016 | Artios Pharma | Series A | 0 |
| 7/2019 | Forendo Pharma | Venture Round | 0 |
| 5/2019 | Storm Therapeutics | Series A | 17.8M |
| 2/2015 | Prexton Therapeutics | Series A | 10M |
| 2/2018 | FanAI | Venture Round | 0 |
| 7/2020 | DNA Script | Series B | 50M |
| 11/2018 | curbFlow | Seed Round | - |
| 9/2017 | DNA Script | Series A | 13.2M |
| 8/2018 | Vantage Point | Pre Seed Round | 0 |
| 11/2020 | Ferroelectric Memory Company | Series B | 0 |
| 10/2013 | Galecto | Series B | 6.3M |
| 7/2016 | Akili Interactive Labs | Series B | 42.4M |
| 12/2022 | Storm Therapeutics | Series B | 30M |
| 1/2012 | Translate Bio | Series A | 20.7M |
| 10/2021 | DNA Script | Series C | 0 |
| 10/2017 | aveni | Series B | 10.5M |
| 2/2022 | Celestial AI | Series A | 56M |
| 3/2022 | Concerto Biosciences | Series A | 24.5M |
| 7/2018 | Mosa Meat | Series A | 0 |
| 12/2019 | Neurable | Series A | 6M |
| 11/2018 | Ribometrix | Series A | 30M |
| 7/2015 | Translate Bio | Series B | 0 |
| 6/2018 | Mighty Bear Games | Seed Round | 2.5M |
| 4/2011 | F-Star Therapeutics | Venture Round | 0 |
| 1/2021 | Theolytics | Series A | 6.8M |
| 10/2022 | Nucleome Therapeutics | Series A | 42.3M |
| 10/2014 | Forendo Pharma | Series A | 0 |
| 6/2018 | Inthera Bioscience | Series A | 0 |
| 9/2020 | Tipe | Seed Round | 2.1M |
| 3/2019 | Biolinq | Series A | 4.8M |
| 3/2023 | PxE | Seed Round | 0 |
| 2/2022 | Micropsi Industries | Series B | 0 |
| 11/2017 | Biolinq | Series A | 0 |
| 1/2010 | F-Star Therapeutics | Series A | 11.5M |
| 5/2009 | Bird Rock Bio | Series A | 13M |
| 6/2020 | Micropsi Industries | Series A | - |
| 10/2013 | F-Star Therapeutics | Series A | 0 |
| 5/2021 | Soteria Biotherapeutics | Series A | 42M |
| 7/2019 | SIMULATE | Seed Round | 7M |
| 4/2016 | Metabomed | Series A | 18M |
| 2/2020 | Scipio Bioscience | Series A | 6.5M |
| 1/2018 | Rewind Therapeutics | Series A | 18.3M |
| 10/2014 | Raze Therapeutics | Series A | 24M |
| 1/2023 | Rewind Therapeutics | Series A | - |
| 4/2020 | FoRx Therapeutics | Seed Round | 10.8M |
| 6/2016 | Storm Therapeutics | Series A | 16M |
| 3/2022 | Altoida | Series A | 0 |
| 9/2020 | SeeQC | Series A | 22.4M |
| 9/2018 | Forendo Pharma | Venture Round | 0 |
| 5/2017 | Inthera Bioscience | Series A | 0 |
| 9/2016 | IOmx Therapeutics | Series A | 44.6M |
| 10/2021 | IOmx Therapeutics | Series B | 0 |
| 7/2016 | Progyny | Series B | 14.7M |
| 3/2020 | Xilio Therapeutics | Series B | 100.5M |
| 11/2015 | ObsEva | Series B | 58.9M |
| 6/2023 | Astraveus | Seed Round | 0 |
| 5/2018 | Akili Interactive Labs | Series C | 0 |
| 5/2021 | Akili Interactive Labs | Series D | 0 |
| 10/2022 | Metalenz | Series B | 0 |
| 1/2023 | Rewind Therapeutics | Series B | - |
| 5/2019 | Altoida | Series A | 6.3M |
| 2/2021 | Medisafe | Series C | 0 |
| 2/2022 | Plexium | Series B | 0 |
| 11/2019 | ResoTher Pharma | Seed Round | 2.4M |
| 12/2022 | Sonde Health | Series B | 19.3M |
| 4/2021 | Anavo Therapeutics | Seed Round | 0 |
| 2/2018 | FanAI | Seed Round | 2.5M |
| 5/2022 | PictorLabs | Series A | 0 |
| 8/2017 | Alcan Systems | Series A | 8.8M |
| 9/2020 | Mosa Meat | Series B | 0 |
| 9/2015 | Asceneuron | Series A | 30.8M |
| 2/2023 | UNISERS | Seed Round | 14M |
| 5/2021 | MemryX | Series A | - |
| 6/2017 | iOnctura | Seed Round | - |
| 4/2014 | Padlock Therapeutics | Series A | 14.7M |
| 3/2013 | Calypso Biotech | Seed Round | 3.3M |
| 10/2017 | Peratech | Equity | 12.4M |
| 6/2009 | Anaphore | Series A | 13M |
| 1/2022 | Future Fertility | Series A | - |
| 4/2009 | Ambrx | Series D | 10M |
| 2/2019 | Calypso Biotech | Series A | 22.7M |
| 9/2021 | Calypso Biotech | Series A | 0 |
| 3/2014 | Bird Rock Bio | Series B | 0 |
| 2/2014 | Synaffix BV | Series A | - |
| 4/2019 | Sonde Health | Series A | 0 |
| 1/2020 | iOnctura | Series A | 16.6M |
| 9/2021 | Legendairy Foods | Series A | 0 |
| 2/2021 | Metalenz | Series A | 10M |
| 1/2012 | Galecto | Seed Round | - |
| 4/2013 | Canbex Therapeutics | Venture Round | 3.2M |
| 6/2023 | Celestial AI | Series B | 100M |
| 3/2017 | Medisafe | Series B | 0 |
| 11/2017 | Wiliot | Series A | 5M |
| 3/2022 | Altoida | Series A | 0 |
| 2/2022 | Plexium | Series B | 0 |
| 2/2022 | Micropsi Industries | Series B | 0 |
| 2/2022 | Celestial AI | Series A | 0 |
| 1/2022 | Future Fertility | Series A | - |
| 11/2021 | NeoLogic (VLSI) | Seed Round | 0 |
| 11/2021 | Biolinq | Series B | 0 |
| 10/2021 | DNA Script | Series C | 0 |
| 10/2021 | IOmx Therapeutics | Series B | 0 |
| 9/2021 | Legendairy Foods | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
